(function(){ var content_array=["

About Sella<\/u><\/strong>s<\/u><\/strong> Life Sciences Group<\/u><\/strong><\/p>\r\n

Sellas Life Sciences Group is an international company with biology and clinical research as characteristics, focusing on innovative drugs R&D in healthcare. The experienced and renowned scientists, doctors and medical experts of their areas constitute the core of Sellas Life Sciences Group. They have the same business purpose: Based on today's innovation and scientific achievements in clinical research, developing the new drugs of tomorrow.<\/p>\r\n

About Chongqing Fochon Pharmaceutical Co., Ltd.<\/u><\/strong><\/p>\r\n

Chongqing Fochon is a subsidiary of Fosun Pharma, a leading healthcare company in the People's Republic of China. Headquartered in Chongqing, China, co-located in San Francisco, CA, Fochon specializes in the discovery of innovative small molecules, with an emphasis on the discovery of effective treatments for cancer and metabolic diseases. Fochon focuses on drug research and discovery from the lead generation and optimization up to the preclinical development.<\/p>\r\n

About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.<\/u><\/strong><\/p>\r\n

Fosun Pharma is a leading healthcare company in the PRC. The Group was established in 1994 with headquarters located in Shanghai, and was listed on the Shanghai Stock Exchange in 1998. In October 2012, though the international financial environment was unfavorable, the Company successfully completed offering and listing H shares in Hong Kong. As a result, the Company has listings in both the A share market and the H share market. The Group has achieved significant results with strengthened corporate governance and investor relationship management. In addition to the SSE 180 Index, CSI 300 Index, SSE Dividend Index and SSE Corporate Governance Index, Fosun Pharma is also included in the SSE Private Enterprise 50 Index, SSE Social Responsibility Index and CCTV Financial 50 Index. According to IMS Health Incorporated (\"IMS\"), the Group was one of the top five domestic pharmaceutical companies in the PRC by revenue in the pharmaceutical manufacturing segment in 2011. The Group's business operations strategically cover multiple important segments in the healthcare industry value chain, with business segments including pharmaceutical manufacturing, pharmaceutical distribution and retail, healthcare services and diagnostic products and medical devices.<\/p>\r\n

Additional information about Fosun Pharma is available at http:\/\/www.fosunpharma.com<\/a>.<\/p>\r\n

For further information, please contact:<\/p>\r\n

Porda Havas International Finance Communications Group<\/strong><\/p>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Mr. Paul Sham<\/td>\r\n+852-3150-6730<\/td>\r\npaul.sham@pordahavas.com<\/a> <\/td>\r\n<\/tr>\r\n
Mr. Bunny Lee<\/td>\r\n+852-3150-6707<\/td>\r\nbunny.lee@pordahavas.com<\/a> <\/td>\r\n<\/tr>\r\n
Ms. Erin Wu<\/td>\r\n+852-3150-6726<\/td>\r\nerin.wu@pordahavas.com<\/a> <\/td>\r\n<\/tr>\r\n
Ms. Chris Wang<\/td>\r\n+852-3150-6714<\/td>\r\nchris.wang@pordahavas.com<\/a> <\/td>\r\n<\/tr>\r\n
Fax: +852-3150-6728<\/td>\r\n <\/td>\r\n <\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>"]; $("#dvExtra").html(content_array[0]);})();